Skip to main content
Clinical Trials/JPRN-UMIN000022166
JPRN-UMIN000022166
Completed
未知

Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients -a randomized comparative study of vonoprazan vs esomeprazole - - Study of symptom improvement effect of vonoprazan and esomeprazole in reflux esophagitis patients

Department of Gastroenterology, Sapporo-kosei General Hospital0 sites40 target enrollmentMay 6, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Reflux esophagitis
Sponsor
Department of Gastroenterology, Sapporo-kosei General Hospital
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 6, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Gastroenterology, Sapporo-kosei General Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients with warning signs such as vomiting, gastrointestinal bleeding (including findings of hematemesis, melena, and anemia), and sudden weight loss 2\.Patients confirmed or suspected malignant lesion 3\.Patients with a history of gastrointestinal resection or vagotomy 4\.Patients in Irritable Bowel Syndrome 5\.Patients whose participation in this study would be contraindicated due to complications such as serious hepatic disease, renal disease, or cardiac disease. 6\.Women who are pregnant or who may possibly be pregnant, and lactating mothers 7\.Other patients whom the investigator considers unsuitable for admission to the study

Outcomes

Primary Outcomes

Not specified

Similar Trials